世界の新規経口抗凝固薬（NOAC）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Novel Oral AntiCoagulants (NOAC) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14843 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、新規経口抗凝固薬（NOAC）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。新規経口抗凝固薬（NOAC）の種類別市場規模（直接トロンビン阻害剤、直接第Xa因子阻害剤）、用途別市場規模（深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・新規経口抗凝固薬（NOAC）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Bristol-Myers Squibb、Boehringer Ingelheim、Sanofi、Daiichi Sankyo、Armatheon、Aspen、AstraZeneca、Bayer、Cellceutix、Cosmo Pharmaceuticals、CSL Behring、Eisai、GSK、Marathon Pharmaceuticals、Ockham Biotech、Perosphere ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：直接トロンビン阻害剤、直接第Xa因子阻害剤 ・用途別分析2016年-2026年：深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他 ・新規経口抗凝固薬（NOAC）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・新規経口抗凝固薬（NOAC）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・新規経口抗凝固薬（NOAC）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・新規経口抗凝固薬（NOAC）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・新規経口抗凝固薬（NOAC）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Novel Oral AntiCoagulants (NOAC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Novel Oral AntiCoagulants (NOAC) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Novel Oral AntiCoagulants (NOAC) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Novel Oral AntiCoagulants (NOAC) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors

Market segment by Application can be divided into
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others

The key market players for global Novel Oral AntiCoagulants (NOAC) market are listed below:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Novel Oral AntiCoagulants (NOAC) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Novel Oral AntiCoagulants (NOAC), with price, sales, revenue and global market share of Novel Oral AntiCoagulants (NOAC) from 2019 to 2021.
Chapter 3, the Novel Oral AntiCoagulants (NOAC) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Novel Oral AntiCoagulants (NOAC) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Novel Oral AntiCoagulants (NOAC) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Novel Oral AntiCoagulants (NOAC) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Novel Oral AntiCoagulants (NOAC) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Novel Oral AntiCoagulants (NOAC) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Novel Oral AntiCoagulants (NOAC) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Global Novel Oral AntiCoagulants (NOAC) Market Size & Forecast
1.4.1 Global Novel Oral AntiCoagulants (NOAC) Sales in Value (2016-2026))
1.4.2 Global Novel Oral AntiCoagulants (NOAC) Sales in Volume (2016-2026)
1.4.3 Global Novel Oral AntiCoagulants (NOAC) Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Novel Oral AntiCoagulants (NOAC) Production Capacity Analysis
1.5.1 Global Novel Oral AntiCoagulants (NOAC) Total Production Capacity (2016-2026)
1.5.2 Global Novel Oral AntiCoagulants (NOAC) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Novel Oral AntiCoagulants (NOAC) Market Drivers
1.6.2 Novel Oral AntiCoagulants (NOAC) Market Restraints
1.6.3 Novel Oral AntiCoagulants (NOAC) Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product and Services
2.1.4 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business
2.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product and Services
2.2.4 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product and Services
2.3.4 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Product and Services
2.4.4 Sanofi Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Daiichi Sankyo
2.5.1 Daiichi Sankyo Details
2.5.2 Daiichi Sankyo Major Business
2.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product and Services
2.5.4 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Armatheon
2.6.1 Armatheon Details
2.6.2 Armatheon Major Business
2.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Product and Services
2.6.4 Armatheon Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Aspen
2.7.1 Aspen Details
2.7.2 Aspen Major Business
2.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Product and Services
2.7.4 Aspen Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Product and Services
2.8.4 AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Product and Services
2.9.4 Bayer Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cellceutix
2.10.1 Cellceutix Details
2.10.2 Cellceutix Major Business
2.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Product and Services
2.10.4 Cellceutix Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Cosmo Pharmaceuticals
2.11.1 Cosmo Pharmaceuticals Details
2.11.2 Cosmo Pharmaceuticals Major Business
2.11.3 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
2.11.4 Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 CSL Behring
2.12.1 CSL Behring Details
2.12.2 CSL Behring Major Business
2.12.3 CSL Behring Novel Oral AntiCoagulants (NOAC) Product and Services
2.12.4 CSL Behring Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Eisai
2.13.1 Eisai Details
2.13.2 Eisai Major Business
2.13.3 Eisai Novel Oral AntiCoagulants (NOAC) Product and Services
2.13.4 Eisai Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 GSK
2.14.1 GSK Details
2.14.2 GSK Major Business
2.14.3 GSK Novel Oral AntiCoagulants (NOAC) Product and Services
2.14.4 GSK Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Marathon Pharmaceuticals
2.15.1 Marathon Pharmaceuticals Details
2.15.2 Marathon Pharmaceuticals Major Business
2.15.3 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
2.15.4 Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Ockham Biotech
2.16.1 Ockham Biotech Details
2.16.2 Ockham Biotech Major Business
2.16.3 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product and Services
2.16.4 Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Perosphere
2.17.1 Perosphere Details
2.17.2 Perosphere Major Business
2.17.3 Perosphere Novel Oral AntiCoagulants (NOAC) Product and Services
2.17.4 Perosphere Novel Oral AntiCoagulants (NOAC) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Novel Oral AntiCoagulants (NOAC) Sales by Manufacturer
3.1 Global Novel Oral AntiCoagulants (NOAC) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Novel Oral AntiCoagulants (NOAC)
3.4 Market Concentration Rate
3.4.1 Top 3 Novel Oral AntiCoagulants (NOAC) Manufacturer Market Share
3.4.2 Top 6 Novel Oral AntiCoagulants (NOAC) Manufacturer Market Share
3.5 Global Novel Oral AntiCoagulants (NOAC) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Novel Oral AntiCoagulants (NOAC) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Novel Oral AntiCoagulants (NOAC) Market Size by Region
4.1.1 Global Novel Oral AntiCoagulants (NOAC) Sales in Volume by Region (2016-2026)
4.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Region (2016-2026)
4.2 North America Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026)
4.3 Europe Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026)
4.4 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026)
4.5 South America Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026)
4.6 Middle East and Africa Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Novel Oral AntiCoagulants (NOAC) Sales in Volume by Type (2016-2026)
5.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Type (2016-2026)
5.3 Global Novel Oral AntiCoagulants (NOAC) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Novel Oral AntiCoagulants (NOAC) Sales in Volume by Application (2016-2026)
6.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Application (2016-2026)
6.3 Global Novel Oral AntiCoagulants (NOAC) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2026)
7.2 North America Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2026)
7.3 North America Novel Oral AntiCoagulants (NOAC) Market Size by Country
7.3.1 North America Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2016-2026)
7.3.2 North America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2026)
8.2 Europe Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2026)
8.3 Europe Novel Oral AntiCoagulants (NOAC) Market Size by Country
8.3.1 Europe Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2016-2026)
8.3.2 Europe Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2026)
9.2 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2026)
9.3 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size by Region
9.3.1 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2026)
10.2 South America Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2026)
10.3 South America Novel Oral AntiCoagulants (NOAC) Market Size by Country
10.3.1 South America Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2016-2026)
10.3.2 South America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2026)
11.2 Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2026)
11.3 Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size by Country
11.3.1 Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Novel Oral AntiCoagulants (NOAC) Typical Distributors
12.3 Novel Oral AntiCoagulants (NOAC) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Novel Oral AntiCoagulants (NOAC) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Novel Oral AntiCoagulants (NOAC) Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product and Services
Table 6. Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Major Business
Table 9. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product and Services
Table 10. Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product and Services
Table 14. Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Novel Oral AntiCoagulants (NOAC) Product and Services
Table 18. Sanofi Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 20. Daiichi Sankyo Major Business
Table 21. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product and Services
Table 22. Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Armatheon Basic Information, Manufacturing Base and Competitors
Table 24. Armatheon Major Business
Table 25. Armatheon Novel Oral AntiCoagulants (NOAC) Product and Services
Table 26. Armatheon Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Aspen Basic Information, Manufacturing Base and Competitors
Table 28. Aspen Major Business
Table 29. Aspen Novel Oral AntiCoagulants (NOAC) Product and Services
Table 30. Aspen Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca Major Business
Table 33. AstraZeneca Novel Oral AntiCoagulants (NOAC) Product and Services
Table 34. AstraZeneca Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bayer Basic Information, Manufacturing Base and Competitors
Table 36. Bayer Major Business
Table 37. Bayer Novel Oral AntiCoagulants (NOAC) Product and Services
Table 38. Bayer Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cellceutix Basic Information, Manufacturing Base and Competitors
Table 40. Cellceutix Major Business
Table 41. Cellceutix Novel Oral AntiCoagulants (NOAC) Product and Services
Table 42. Cellceutix Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Cosmo Pharmaceuticals Major Business
Table 45. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
Table 46. Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 48. CSL Behring Major Business
Table 49. CSL Behring Novel Oral AntiCoagulants (NOAC) Product and Services
Table 50. CSL Behring Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Eisai Basic Information, Manufacturing Base and Competitors
Table 52. Eisai Major Business
Table 53. Eisai Novel Oral AntiCoagulants (NOAC) Product and Services
Table 54. Eisai Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. GSK Basic Information, Manufacturing Base and Competitors
Table 56. GSK Major Business
Table 57. GSK Novel Oral AntiCoagulants (NOAC) Product and Services
Table 58. GSK Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Marathon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Marathon Pharmaceuticals Major Business
Table 61. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Product and Services
Table 62. Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Ockham Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Ockham Biotech Major Business
Table 65. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Product and Services
Table 66. Ockham Biotech Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Perosphere Basic Information, Manufacturing Base and Competitors
Table 68. Perosphere Major Business
Table 69. Perosphere Novel Oral AntiCoagulants (NOAC) Product and Services
Table 70. Perosphere Novel Oral AntiCoagulants (NOAC) Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Novel Oral AntiCoagulants (NOAC) Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 72. Global Novel Oral AntiCoagulants (NOAC) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Novel Oral AntiCoagulants (NOAC), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Novel Oral AntiCoagulants (NOAC) Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 75. Head Office and Novel Oral AntiCoagulants (NOAC) Production Site of Key Manufacturer
Table 76. Novel Oral AntiCoagulants (NOAC) New Entrant and Capacity Expansion Plans
Table 77. Novel Oral AntiCoagulants (NOAC) Mergers & Acquisitions in the Past Five Years
Table 78. Global Novel Oral AntiCoagulants (NOAC) Sales by Region (2016-2021e) & (K Pcs)
Table 79. Global Novel Oral AntiCoagulants (NOAC) Sales by Region (2021-2026) & (K Pcs)
Table 80. Global Novel Oral AntiCoagulants (NOAC) Revenue by Region (2016-2021e) & (USD Million)
Table 81. Global Novel Oral AntiCoagulants (NOAC) Revenue by Region (2021-2026) & (USD Million)
Table 82. Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 83. Global Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 84. Global Novel Oral AntiCoagulants (NOAC) Revenue by Type (2016-2021e) & (USD Million)
Table 85. Global Novel Oral AntiCoagulants (NOAC) Revenue by Type (2021-2026) & (USD Million)
Table 86. Global Novel Oral AntiCoagulants (NOAC) Price by Type (2016-2021e) & (USD/Pcs)
Table 87. Global Novel Oral AntiCoagulants (NOAC) Price by Type (2021-2026) & (USD/Pcs)
Table 88. Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 89. Global Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 90. Global Novel Oral AntiCoagulants (NOAC) Revenue by Application (2016-2021e) & (USD Million)
Table 91. Global Novel Oral AntiCoagulants (NOAC) Revenue by Application (2021-2026) & (USD Million)
Table 92. Global Novel Oral AntiCoagulants (NOAC) Price by Application (2016-2021e) & (USD/Pcs)
Table 93. Global Novel Oral AntiCoagulants (NOAC) Price by Application (2021-2026) & (USD/Pcs)
Table 94. North America Novel Oral AntiCoagulants (NOAC) Sales by Country (2016-2021e) & (K Pcs)
Table 95. North America Novel Oral AntiCoagulants (NOAC) Sales by Country (2021-2026) & (K Pcs)
Table 96. North America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2021e) & (USD Million)
Table 97. North America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2021-2026) & (USD Million)
Table 98. North America Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 99. North America Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 100. North America Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 101. North America Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 102. Europe Novel Oral AntiCoagulants (NOAC) Sales by Country (2016-2021e) & (K Pcs)
Table 103. Europe Novel Oral AntiCoagulants (NOAC) Sales by Country (2021-2026) & (K Pcs)
Table 104. Europe Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2021e) & (USD Million)
Table 105. Europe Novel Oral AntiCoagulants (NOAC) Revenue by Country (2021-2026) & (USD Million)
Table 106. Europe Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 107. Europe Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 108. Europe Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 109. Europe Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 110. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Region (2016-2021e) & (K Pcs)
Table 111. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Region (2021-2026) & (K Pcs)
Table 112. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Region (2016-2021e) & (USD Million)
Table 113. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue by Region (2021-2026) & (USD Million)
Table 114. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 115. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 116. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 117. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 118. South America Novel Oral AntiCoagulants (NOAC) Sales by Country (2016-2021e) & (K Pcs)
Table 119. South America Novel Oral AntiCoagulants (NOAC) Sales by Country (2021-2026) & (K Pcs)
Table 120. South America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2021e) & (USD Million)
Table 121. South America Novel Oral AntiCoagulants (NOAC) Revenue by Country (2021-2026) & (USD Million)
Table 122. South America Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 123. South America Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 124. South America Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 125. South America Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 126. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Country (2016-2021e) & (K Pcs)
Table 127. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Country (2021-2026) & (K Pcs)
Table 128. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue by Country (2016-2021e) & (USD Million)
Table 129. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue by Country (2021-2026) & (USD Million)
Table 130. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Type (2016-2021e) & (K Pcs)
Table 131. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Type (2021-2026) & (K Pcs)
Table 132. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Application (2016-2021e) & (K Pcs)
Table 133. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales by Application (2021-2026) & (K Pcs)
Table 134. Direct Channel Pros & Cons
Table 135. Indirect Channel Pros & Cons
Table 136. Novel Oral AntiCoagulants (NOAC) Typical Distributors
Table 137. Novel Oral AntiCoagulants (NOAC) Typical Customers
List of Figures
Figure 1. Novel Oral AntiCoagulants (NOAC) Picture
Figure 2. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type in 2020
Figure 3. Direct Thrombin Inhibitors
Figure 4. Direct Factor Xa Inhibitors
Figure 5. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application in 2020
Figure 6. Deep Vein Thrombosis (DVT)
Figure 7. Pulmonary Embolism
Figure 8. Acute Coronary Syndrome
Figure 9. Hemodialysis
Figure 10. Others
Figure 11. Global Novel Oral AntiCoagulants (NOAC) Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Novel Oral AntiCoagulants (NOAC) Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Novel Oral AntiCoagulants (NOAC) Sales (2016-2026) & (K Pcs)
Figure 14. Global Novel Oral AntiCoagulants (NOAC) Price by Type (2016-2026) & (USD/Pcs)
Figure 15. Global Novel Oral AntiCoagulants (NOAC) Production Capacity (2016-2026) & (K Pcs)
Figure 16. Global Novel Oral AntiCoagulants (NOAC) Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Novel Oral AntiCoagulants (NOAC) Market Drivers
Figure 18. Novel Oral AntiCoagulants (NOAC) Market Restraints
Figure 19. Novel Oral AntiCoagulants (NOAC) Market Trends
Figure 20. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Manufacturer in 2020
Figure 21. Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Manufacturer in 2020
Figure 22. Novel Oral AntiCoagulants (NOAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Novel Oral AntiCoagulants (NOAC) Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Novel Oral AntiCoagulants (NOAC) Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Region (2016-2026)
Figure 26. Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Region (2016-2026)
Figure 27. North America Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026) & (USD Million)
Figure 28. Europe Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026) & (USD Million)
Figure 30. South America Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue (2016-2026) & (USD Million)
Figure 32. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2016-2026)
Figure 33. Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Type (2016-2026)
Figure 34. Global Novel Oral AntiCoagulants (NOAC) Price by Type (2016-2026) & (USD/Pcs)
Figure 35. Global Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 36. Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Application (2016-2026)
Figure 37. Global Novel Oral AntiCoagulants (NOAC) Price by Application (2016-2026) & (USD/Pcs)
Figure 38. North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2016-2026)
Figure 39. North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 40. North America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Country (2016-2026)
Figure 41. North America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Country (2016-2026)
Figure 42. United States Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2016-2026)
Figure 46. Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 47. Europe Novel Oral AntiCoagulants (NOAC) Sales Market Share by Country (2016-2026)
Figure 48. Europe Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Country (2016-2026)
Figure 49. Germany Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Region (2016-2026)
Figure 58. China Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2016-2026)
Figure 65. South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 66. South America Novel Oral AntiCoagulants (NOAC) Sales Market Share by Country (2016-2026)
Figure 67. South America Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---